Overview

An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Obtain information on whether the medication Perampanel reduces tremor in people with essential tremor and is well-tolerated.
Phase:
Phase 2
Details
Lead Sponsor:
VA Greater Los Angeles Healthcare System